BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19450181)

  • 1. Novel therapeutics for the treatment of metastatic melanoma.
    Mansfield AS; Markovic SN
    Future Oncol; 2009 May; 5(4):543-57. PubMed ID: 19450181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic malignant melanoma.
    Markovic SN; Erickson LA; Flotte TJ; Kottschade LA; McWilliams RR; Jakub JW; Farley DR; Tran NV; Schild SE; Olivier KR; Vuk-Pavlovic S; Sekulic A; Weenig RH; Pulido JS; Quevedo JF; Vile RG; Wiseman GA; Stoian I; Pittelkow MR;
    G Ital Dermatol Venereol; 2009 Feb; 144(1):1-26. PubMed ID: 19218908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma.
    Benson C; Gore ME
    Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
    [No Abstract]   [Full Text] [Related]  

  • 4. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications and options for systemic therapy in melanoma.
    Sondak VK; Gibney GT
    Surg Clin North Am; 2014 Oct; 94(5):1049-58, viii. PubMed ID: 25245967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy for cutaneous melanoma.
    Treisman J; Garlie N
    Clin Plast Surg; 2010 Jan; 37(1):127-46. PubMed ID: 19914464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of malignant melanoma.
    Kadison AS; Morton DL
    Surg Clin North Am; 2003 Apr; 83(2):343-70. PubMed ID: 12744613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma--future prospects.
    Lugović L; Situm M; Kos L
    Acta Dermatovenerol Croat; 2005; 13(1):36-43. PubMed ID: 15788145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma: from darkness to promise.
    Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
    Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
    Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
    G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic treatment of metastatic melanoma: new approaches.
    Hamid O; Boasberg PD; Rosenthal K; O'Day SJ
    J Surg Oncol; 2011 Sep; 104(4):425-9. PubMed ID: 21858838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell vaccination as a treatment modality for melanoma.
    Eubel J; Enk AH
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1631-42. PubMed ID: 19895246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial approach to treatment of melanoma.
    Ashworth MT; Daud AI
    Hematol Oncol Clin North Am; 2014 Jun; 28(3):601-12. PubMed ID: 24880950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].
    Enk AH; Becker JC; Schuler G
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and planned multicenter trials for patients with primary or metastatic melanoma.
    Sondak VK; Han D; Deneve J; Kudchadkar R
    J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of melanoma.
    Brown CK; Kirkwood JM
    Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches in metastatic melanoma: biological and molecular targeted therapies.
    Lejeune FJ; Rimoldi D; Speiser D
    Expert Rev Anticancer Ther; 2007 May; 7(5):701-13. PubMed ID: 17492933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.
    Dillman RO; Cornforth AN; Depriest C; McClay EF; Amatruda TT; de Leon C; Ellis RE; Mayorga C; Carbonell D; Cubellis JM
    J Immunother; 2012 Oct; 35(8):641-9. PubMed ID: 22996370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.